UBS Group’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-226
| Closed | -$8.24K | – | 9107 |
|
|
2024
Q2 | $8.24K | Buy |
+226
| New | +$8.24K | ﹤0.01% | 6652 |
|
|
2024
Q1 | – | Sell |
-1,088
| Closed | -$39.5K | – | 8826 |
|
|
2023
Q4 | $39.5K | Buy |
1,088
+803
| +282% | +$29.2K | ﹤0.01% | 5475 |
|
|
2023
Q3 | $8.58K | Buy |
285
+48
| +20% | +$1.45K | ﹤0.01% | 6040 |
|
|
2023
Q2 | $8.52K | Sell |
237
-2,093
| -90% | -$75.2K | ﹤0.01% | 6155 |
|
|
2023
Q1 | $77.4K | Buy |
2,330
+1,366
| +142% | +$45.4K | ﹤0.01% | 5054 |
|
|
2022
Q4 | $32.4K | Sell |
964
-451
| -32% | -$15.2K | ﹤0.01% | 5992 |
|
|
2022
Q3 | $49K | Buy |
1,415
+840
| +146% | +$29.1K | ﹤0.01% | 5307 |
|
|
2022
Q2 | $19K | Sell |
575
-3,264
| -85% | -$108K | ﹤0.01% | 5922 |
|
|
2022
Q1 | $152K | Buy |
3,839
+2,447
| +176% | +$96.9K | ﹤0.01% | 4593 |
|
|
2021
Q4 | $66K | Buy |
+1,392
| New | +$66K | ﹤0.01% | 5587 |
|
|
2020
Q2 | – | Sell |
-180
| Closed | -$6K | – | 7387 |
|
|
2020
Q1 | $6K | Sell |
180
-177
| -50% | -$5.9K | ﹤0.01% | 6326 |
|
|
2019
Q4 | $14K | Buy |
357
+43
| +14% | +$1.69K | ﹤0.01% | 6036 |
|
|
2019
Q3 | $10K | Buy |
314
+90
| +40% | +$2.87K | ﹤0.01% | 6211 |
|
|
2019
Q2 | $8K | Sell |
224
-165
| -42% | -$5.89K | ﹤0.01% | 6333 |
|
|
2019
Q1 | $14K | Buy |
389
+131
| +51% | +$4.72K | ﹤0.01% | 5770 |
|
|
2018
Q4 | $7K | Buy |
258
+133
| +106% | +$3.61K | ﹤0.01% | 6504 |
|
|
2018
Q3 | $5K | Sell |
125
-60
| -32% | -$2.4K | ﹤0.01% | 6593 |
|
|
2018
Q2 | $6K | Buy |
185
+140
| +311% | +$4.54K | ﹤0.01% | 6497 |
|
|
2018
Q1 | $1K | Buy |
45
+35
| +350% | +$778 | ﹤0.01% | 6779 |
|
|
2017
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 7021 |
|
|
2017
Q1 | – | Sell |
-200
| Closed | -$5K | – | 6880 |
|
|
2016
Q4 | $5K | Buy |
+200
| New | +$5K | ﹤0.01% | 6286 |
|